Back to search

Article

Network analysis and experimental verification of Salvia miltiorrhiza Bunge-Reynoutria japonica Houtt. drug pair in the treatment of non-alcoholic fatty liver disease

2024-05-31

Abstract excerpt

<title>Abstract</title> <p><bold>Context:</bold>There are currently no approved specific clinical drugs for non-alcoholic fatty liver disease (NAFLD). Salvia miltiorrhiza Bunge-Reynoutria japonica Houtt. drug pair (SRDP) has been widely used in the treatment of chronic liver diseases. However, the mechanism of SRDP treating NAFLD remains unclear. <bold>Objective:</bold>Based on network analysis and in vitro exper...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f2221552-3b5d-5718-b8be-489bb10a2726
DOI
10.21203/rs.3.rs-4278923/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Network analysis and experimental verification of Salvia miltiorrhiza Bunge-Reynoutria japonica Houtt. drug pair in the treatment of non-alcoholic fatty liver diseaseDOI 10.21203/rs.3.rs-4278923/v1
Identify Key Active Ingredients and Molecular Mechanisms of Jiangzhi Decoction on Non-alcoholic Fatty Liver Disease by Network Pharmacology AnalysisSemantic proximity
Mechanisms of Cynarine for treatment of Non-alcoholic Fatty Liver Disease Based on the Integration of Network Pharmacology, Molecular Docking and Cell ExperimentSemantic proximity
Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology and molecular dockingSemantic proximity
Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacologySemantic proximity
Exploring the Mechanism of Danggui Shaoyao San in the treatment of Non-alcoholic Fatty Liver Disease: A Study based on Network Pharmacology and Molecular DockingSemantic proximity
Network Pharmacology Reveals the Multiple Mechanisms of Xiaochaihu Decoction in the Treatment of Non-alcoholic Fatty Liver DiseaseSemantic proximity
Huanglian-Hongqu herb pair improves nonalcoholic fatty liver disease via NF-κB/NLRP3 pathway in mice: network pharmacology, molecular docking and experimental validationSemantic proximity
Exploring the Mechanism of Dendrobine in Treating Non-Alcoholic Fatty Liver Disease Based on Network Pharmacology and Experimental ValidationSemantic proximity
Inhibition of Lipid Accumulation in NAFLD Liver by Extract of Rosa laevigata Fruit Extract through Activation of the PI3K-AKT Signaling PathwaySemantic proximity
Exploring anti-nonalcoholic fatty liver disease mechanism of Gardeniae Fructus by combining an animal model with network pharmacology and molecular dockingSemantic proximity
Development of A Novel Anti-Liver Fibrosis Formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysisSemantic proximity
Unraveling Berberine's Multi-Target Mechanism in Combating NAFLD: A Network Pharmacology and In Vitro StudySemantic proximity
Select a neighboring publication to make it the new centre.